Puerto Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 22.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 20.03 Cr
as on 16-11-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 58.38 Cr
as on 16-11-2024
- Satisfied Charges ₹ 25.00 Cr
as on 16-11-2024
- Revenue 30619.19%
(FY 2023)
- Profit -761.75%
(FY 2023)
- Ebitda -374.32%
(FY 2023)
- Net Worth -85.36%
(FY 2023)
- Total Assets 12.88%
(FY 2023)
About Puerto Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 22.00 Cr and a paid-up capital of Rs 20.03 Cr.
The company currently has active open charges totaling ₹58.38 Cr. The company has closed loans amounting to ₹25.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Puerto Life Sciences Private Limited India is Neha Jain as COMPANY SECRETARY. Veerinder Singh, Anju Jolly, and Pramod Sharma serve as directors at the Company.
- CIN/LLPIN
U36990DL2018PTC340100
- Company No.
340100
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Puerto Life Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neha Jain | Company Secretary | 22-Dec-2023 | Current |
Pramod Sharma  | Managing Director | 17-Jul-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anju Jolly | Director | 04-Oct-2018 | Current |
| Veerinder Singh | Director | 25-Oct-2018 | Current |
Financial Performance and Corporate Structure Insights of Puerto Life Sciences.
Puerto Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30619.19% increase. The company also saw a substantial fall in profitability, with a 761.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 85.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Puerto Life Sciences?
In 2023, Puerto Life Sciences had a promoter holding of 85.00% and a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The South Indian Bank Limited Creation Date: 07 Dec 2021 | ₹2.00 Cr | Open |
Hdfc Bank Limited Creation Date: 30 Nov 2021 | ₹55.19 Cr | Open |
The South Indian Bank Limited Creation Date: 24 Mar 2021 | ₹1.19 Cr | Open |
How Many Employees Work at Puerto Life Sciences?
Puerto Life Sciences has a workforce of 144 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Puerto Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Puerto Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
